Cambridge Nutritional Sciences plc (AIM:CNSL)
London flag London · Delayed Price · Currency is GBP · Price in GBX
1.725
-0.025 (-1.43%)
Jul 31, 2026, 4:05 PM GMT

AIM:CNSL Financials Overview

Millions GBP. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Revenue
8.068.339.777.558.546.82
Revenue Growth
-3.25%-14.77%29.53%-11.63%25.28%-30.58%
Gross Profit
5.355.446.053.555.14
Operating Income
-0.54-0.4-0.54-2.72-0.59-0.47
Net Income
1.371.57-0.33-3.86-11.33-2.1
Earnings Per Share
0.010.01-0.00-0.02-0.06-0.01
EPS Growth
-12.90%-----

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
United Kingdom
1.71.651.530.980.470.4
Rest of Europe
1.741.992.062.312.611.78
Americas
1.421.482.36---
India
0.790.690.550.530.510.29
Africa and The Middle East
0.530.611.040.561.210.64
Asia and The Far East
-1.912.241.731.52.59
Total
8.068.339.777.558.546.82

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Cash & Investments
3.594.875.445.121.615.83
Total Debt
0.240.350.150.070.372.84
Net Cash (Debt)
3.364.525.35.041.242.98
Net Cash Growth
-25.71%-14.67%5.06%308.18%-58.61%-
Net Cash Per Share
0.010.020.020.020.010.02

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Operating Cash Flow
-0.27-0.060.61-3.15-3.23-2.42
Capital Expenditures
-0.27-0.23-0.05-0.03-0.97-1.97
Free Cash Flow
-0.54-0.280.56-3.18-4.2-4.38
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Gross Margin
66.44%65.32%61.86%46.98%59.75%58.63%
Operating Margin
-6.70%-4.74%-5.47%-35.98%-6.93%-6.87%
Pretax Margin
16.94%18.80%-7.62%-43.10%-11.13%-8.01%
Profit Margin
16.94%18.80%-3.36%-51.15%-132.72%-30.87%
FCF Margin
-6.71%-3.38%5.72%-42.10%-49.15%-64.32%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
PE Ratio
3.054.63----
Forward PE
-260.00260.00260.00260.00260.00
P/FCF Ratio
--14.69---
PS Ratio
0.520.870.840.980.8221.56